ADALIMUMAB-FKJP for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 68 adverse event reports in the FDA FAERS database where ADALIMUMAB-FKJP was used for Psoriasis.
Most Reported Side Effects for ADALIMUMAB-FKJP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 287 | 16.3% | 13 | 95 |
| Drug ineffective | 285 | 16.2% | 3 | 24 |
| Product dose omission issue | 156 | 8.9% | 8 | 49 |
| Rheumatoid arthritis | 113 | 6.4% | 0 | 29 |
| Crohn's disease | 110 | 6.3% | 0 | 21 |
| Inappropriate schedule of product administration | 105 | 6.0% | 4 | 30 |
| Diarrhoea | 103 | 5.9% | 4 | 35 |
| Pain | 100 | 5.7% | 1 | 33 |
| Covid-19 | 84 | 4.8% | 6 | 51 |
| Arthralgia | 80 | 4.6% | 3 | 21 |
| Fatigue | 79 | 4.5% | 1 | 16 |
| Hospitalisation | 78 | 4.4% | 8 | 78 |
| Illness | 72 | 4.1% | 2 | 27 |
| Malaise | 70 | 4.0% | 1 | 23 |
| Headache | 67 | 3.8% | 1 | 20 |
Other Indications for ADALIMUMAB-FKJP
Rheumatoid arthritis (484)
Crohn's disease (336)
Product used for unknown indication (238)
Psoriatic arthropathy (187)
Ankylosing spondylitis (174)
Axial spondyloarthritis (83)
Colitis ulcerative (83)
Hidradenitis (36)
Juvenile idiopathic arthritis (29)
Uveitis (27)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)